{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:11:33Z","timestamp":1777943493854,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["NCT04229264"],"award-info":[{"award-number":["NCT04229264"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ahj.2020.06.010","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T02:59:10Z","timestamp":1592881150000},"page":"100-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial"],"prefix":"10.1016","volume":"227","author":[{"given":"Rodrigo Bruno","family":"Biagioni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato Delascio","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro Barile","family":"Agati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Sacilotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Wolosker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcone Lima","family":"Sobreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Leonardo","family":"de Freitas Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwaldo Edner","family":"Joviliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walkiria Hueb","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valter Castelli","family":"Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto Augusto","family":"Caffaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Fioranelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonno","family":"Van Bellen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan Benaduce","family":"Casella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald Jos\u00e9 Ribeiro","family":"Fidelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald Luiz Gomes","family":"Flumignan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony James","family":"Comerota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Ramacciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2020.06.010_bb0005","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J."},{"key":"10.1016\/j.ahj.2020.06.010_bb0010","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ahj.2020.06.010_bb0015","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2018.08.002","article-title":"Pathology of peripheral artery disease in patients with critical limb ischemia","volume":"72","author":"Narula","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.ahj.2020.06.010_bb0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa065959","article-title":"Oral anticoagulant and antiplatelet therapy and peripheral arterial disease","volume":"357","author":"Warfarin Antiplatelet Vascular Evaluation Trial I","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2020.06.010_bb0025","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2020.06.010_bb0030","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"The New England journal of medicine."},{"key":"10.1016\/j.ahj.2020.06.010_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1526602818760488","article-title":"Edoxaban plus aspirin vs dual antiplatelet therapy in endovascular treatment of patients with peripheral artery disease: results of the ePAD Trial","volume":"25","author":"Moll","year":"2018","journal-title":"J Endovasc Ther."},{"key":"10.1016\/j.ahj.2020.06.010_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003468","article-title":"Percutaneous transluminal angioplasty in patients with infrapopliteal arterial disease: systematic review and meta-analysis","volume":"9","author":"Mustapha","year":"2016","journal-title":"Circ Cardiovasc Interv."},{"key":"10.1016\/j.ahj.2020.06.010_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejvs.2017.04.020","article-title":"A comparison of outcomes in patients with infrapopliteal disease randomized to vein bypass or plain balloon angioplasty in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL) Trial","volume":"54","author":"Popplewell","year":"2017","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"10.1016\/j.ahj.2020.06.010_bb0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jvir.2009.01.010","article-title":"Atherosclerotic risk factors and segmental distribution in symptomatic peripheral artery disease","volume":"20","author":"Ozkan","year":"2009","journal-title":"J Vasc Interv Radiol."},{"key":"10.1016\/j.ahj.2020.06.010_bb0055","first-page":"Cd002071","article-title":"Antiplatelet and anticoagulant drugs for prevention of restenosis\/reocclusion following peripheral endovascular treatment","author":"Dorffler-Melly","year":"2005","journal-title":"The Cochrane database of systematic reviews"},{"key":"10.1016\/j.ahj.2020.06.010_bb0060","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jvs.2006.07.044","article-title":"Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: A randomized controlled trial","volume":"44","author":"Koppensteiner","year":"2006","journal-title":"Journal of Vascular Surgery."},{"key":"10.1016\/j.ahj.2020.06.010_bb0065","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/1358836X9800300314","article-title":"Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events","volume":"3","author":"Creager","year":"1998","journal-title":"Vascular medicine (London, England)"},{"key":"10.1016\/j.ahj.2020.06.010_bb0070","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/1358863X18775594","article-title":"Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial","volume":"23","author":"Berger","year":"2018","journal-title":"Vascular medicine (London, England)"},{"key":"10.1016\/j.ahj.2020.06.010_bb0075","first-page":"1509","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019"},{"key":"10.1016\/j.ahj.2020.06.010_bb0080","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med."},{"issue":"Suppl S","key":"10.1016\/j.ahj.2020.06.010_bb0085","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ahj.2020.06.010_bb0090","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jvs.2018.04.018","article-title":"The Society for Vascular Surgery practice guidelines on follow-up after vascular surgery arterial procedures","volume":"68","author":"Zierler","year":"2018","journal-title":"J Vasc Surg."},{"key":"10.1016\/j.ahj.2020.06.010_bb0095","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jvs.2011.07.099","article-title":"Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease","volume":"55","author":"Bosiers","year":"2012","journal-title":"J Vasc Surg."},{"key":"10.1016\/j.ahj.2020.06.010_bb0100","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Farber A, Guzman RJ, Hamdan AD, Landry GJ, Yamaguchi DJ and Society for Vascular S. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J Vasc Surg."},{"key":"10.1016\/j.ahj.2020.06.010_bb0105","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: The COMPASS Trial","volume":"71","author":"Anand","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.ahj.2020.06.010_bb0110","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"Journal of Thrombosis and Hemostasis."}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870320301903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870320301903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:04:58Z","timestamp":1757570698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870320301903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":22,"alternative-id":["S0002870320301903"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2020.06.010","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2020.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}